ST. LOUIS, Jan. 14, 2025 (GLOBE NEWSWIRE) — Stereotaxis STXS, a pioneer and world chief in surgical robotics for minimally invasive endovascular intervention, as we speak introduced that physicians at Oulu College Hospital in Finland have efficiently handled the primary sufferers utilizing the superior Genesis Robotic Magnetic Navigation (RMN) System from Stereotaxis.
Oulu College Hospital has vital expertise pioneering the usage of robotic applied sciences for the remedy of coronary heart arrhythmias, having handled over 2,000 sufferers with authentic variations of the expertise. The implementation of the most recent Genesis System introduces vital advances in Robotic Magnetic Navigation expertise to the northern areas of Finland. Robotic Magnetic Navigation introduces the advantages of robotic precision and security to cardiac ablation, a standard minimally invasive process to deal with arrhythmias. Tens of hundreds of thousands of people worldwide undergo from arrhythmias – irregular coronary heart rhythms that end result when the guts beats too shortly, too slowly, or with an irregular sample. When left untreated, arrhythmias might considerably improve the danger of stroke, coronary heart failure, and sudden cardiac arrest.
“For 15 years, superior robotic expertise has been important to our workforce, permitting us to offer superior affected person take care of sufferers with advanced cardiac arrhythmias,” stated Dr. Jarkko Magga, Cardiac Electrophysiologist at Oulu College. “We’re happy to proceed to offer the best high quality affected person care with the precision and stability provided by the extra superior Genesis System.”
“We’re proud to reinforce and increase our partnership with Oulu College to make sure sufferers in Finland have entry to main cardiac care,” stated David Fischel, Chairman and CEO of Stereotaxis. “We look ahead to persevering with to assist their profitable and impactful robotic coronary heart rhythm follow.”
About Stereotaxis
Stereotaxis STXS is a pioneer and world chief in revolutionary surgical robotics for minimally invasive endovascular intervention. Its mission is the invention, improvement and supply of robotic methods, devices, and knowledge options for the interventional laboratory. These improvements assist physicians present unsurpassed affected person care with robotic precision and security, increase entry to minimally invasive remedy, and improve the productiveness, connectivity, and intelligence within the working room. Stereotaxis expertise has been used to deal with over 150,000 sufferers throughout the US, Europe, Asia, and elsewhere. For extra data, please go to www.Stereotaxis.com.
This press launch contains statements that will represent “forward-looking” statements, often containing the phrases “consider”, “estimate”, “mission”, “count on” or comparable expressions. Ahead-looking statements inherently contain dangers and uncertainties that would trigger precise outcomes to vary materially. Elements that will trigger or contribute to such variations embody, however are usually not restricted to, the Firm’s means to handle bills at sustainable ranges, acceptance of the Firm’s merchandise within the market, the impact of worldwide financial circumstances on the power and willingness of consumers to buy its expertise, aggressive components, modifications ensuing from healthcare coverage, dependence upon third-party distributors, timing of regulatory approvals, the affect of pandemics or different disasters, and statements referring to our current acquisition of APT, together with any advantages anticipated from the acquisition, and different dangers mentioned within the Firm’s periodic and different filings with the Securities and Change Fee. By making these forward-looking statements, the Firm undertakes no obligation to replace these statements for revisions or modifications after the date of this launch. There might be no assurance that the Firm will acknowledge income associated to its buy orders and different commitments as a result of a few of these buy orders and different commitments are topic to contingencies which might be exterior of the Firm’s management and could also be revised, modified, delayed, or canceled.
Stereotaxis Contacts:
David L. Fischel
Chairman and Chief Government Officer
Kimberly Peery
Chief Monetary Officer
314-678-6100
[email protected]
Market Information and Knowledge dropped at you by Benzinga APIs
© 2025 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
